Strategies for Avoiding Typical Drug-Drug Interactions and Drug-Related Problems in Patients with Vascular Diseases.

Klaus Peter Schmelzer, Dominik Liebetrau, Wolfgang Kämmerer, Christine Meisinger, Alexander Hyhlik-Dürr

Abstract read

In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Next Generation Experimental Models of Venous Physiology and Pathology: Examining Human Relevance in Recapitulating Lower Extremity Flow and Valve Function in New Approach Methods (NAMs).Small (Weinheim an der Bergstrasse, Germany) · 2026
Review
Optimizing the Pharmacotherapy of Vascular Surgery Patients at Hospital Admission and Discharge (PHAROS): Protocol for a Quasi-Experimental Clinical Uncontrolled Trial.JMIR research protocols · 2025
Article
Pharmacist-led interventions for vascular surgery patients: a prospective study on reducing drug-related problems.BMC health services research · 2024
Observational

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Klaus Peter SchmelzerPharmacy Department, University of Augsburg, 86156 Augsburg, Germany.ORCID 0000-0001-8767-2659

Dominik LiebetrauVascular Surgery, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.

Wolfgang KämmererPharmacy Department, University of Augsburg, 86156 Augsburg, Germany.

Christine MeisingerEpidemiology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.

Alexander Hyhlik-DürrVascular Surgery, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug-Related Side Effects and Adverse ReactionsVascular DiseasesDrug InteractionsHospitalsHumansPharmacistsadverse reactionsdrug interactionsdrug-related side effectsmedication errorsmedication reconciliationpharmacy service hospital

Identifiers

PMID37109738

DOI10.3390/medicina59040780

PMCPMC10142821

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.